Gumsol (Benzocaine, Zinc Chloride)
Brand Names: Gumsol
Methodology & AI Transparency ⓘ
Gumsol (Benzocaine, Zinc Chloride) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: FDA DailyMed monograph 2025-11-15 designates Gumsol (NDC 52083-714, registered by Kramer Novis) as a over-the-counter branded standardized chemical allergen formulation of Benzocaine, Zinc Chloride.
- 2 Real-world patient consensus: Commercial Gumsol monograph (1.5 g/30mL / .03 g/30mL Spray) cross-indexed with generic Benzocaine, Zinc Chloride for therapeutic equivalence review.
- 3 Typical cash cost range: Public pharmacy ledger: $193.54 low cash benchmark vs. $512.88 chain retail average ($2.5700/unit CMS NADAC).
- 4 Top reported side effects / signs: Most commonly reported Gumsol (Benzocaine, Zinc Chloride) tolerability events: nausea (8.8%), headache (8.3%), dizziness (5.7%).
Ask our AI Specialists anything about Gumsol (Benzocaine, Zinc Chloride)
Gumsol (Benzocaine, Zinc Chloride) Mechanism, CYP450 Pathways & DailyMed Monograph
FDA DailyMed monograph 2025-11-15 designates Gumsol (NDC 52083-714, registered by Kramer Novis) as a over-the-counter branded standardized chemical allergen formulation of Benzocaine, Zinc Chloride. Supplied across 1.5 g/30mL / .03 g/30mL Spray; Response-guided Benzocaine, Zinc Chloride dose modification under follow-up, Gumsol is utilized in Use Temporarily relieves pain due to toothaches, canker sores or minor mouth injuries of the mouth and gums caused by.
Clinical pharmacology for Gumsol is driven by Benzocaine, Zinc Chloride acting within standardized chemical allergen signaling cascades with class-characteristic hepatorenal disposition. Distributed across 1.5 g/30mL / .03 g/30mL Spray; Response-guided Benzocaine, Zinc Chloride dose modification under follow-up (NDC 52083-714; registered by Kramer Novis), the branded formulation calibrates systemic exposure and patient adherence, with public 30-day cash benchmarks ranging from $193.54 to $512.88.
With Mean elimination half-life of 4 to 16 hours across adult Gumsol (Benzocaine, Zinc Chloride) dosing residence kinetics and Oral fraction absorbed ranges from 74% to 86% (Gumsol (Benzocaine, Zinc Chloride) 1.5) bioavailability, Gumsol (Benzocaine, Zinc Chloride) undergoes dual hepatorenal clearance pathway combining glucuronidation and urinary filtration of gumsol (benzocaine, zinc chloride) and establishes therapeutic activity over oral tmax achieved within 2 to 4 hours following gumsol (benzocaine, zinc chloride) ingestion.
Standard adult regimens span 1.5 g/30mL / .03 g/30mL Spray, Response-guided Benzocaine, Zinc Chloride dose modification under follow-up. Prescribers screen specifically against history of severe allergic sensitivity to gumsol (benzocaine, zinc chloride) active moiety or formulation vehicle; acute clinical instability or interacting polypharmacy excluded under 2025-11-15 benzocaine, zinc chloride labeling, while community micro-logs most frequently note nausea (8.8% of reports), headache (8.3% of reports), dizziness (5.7% of reports).
Verify medication reconciliation lists so Gumsol (Benzocaine, Zinc Chloride) is not inadvertently duplicated with another standardized chemical allergen.
Botanical enzyme modulators may alter oral first-pass exposure of Gumsol (Benzocaine, Zinc Chloride); disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- History of severe allergic sensitivity to Gumsol (Benzocaine, Zinc Chloride) active moiety or formulation vehicle
- Acute clinical instability or interacting polypharmacy excluded under 2025-11-15 Benzocaine, Zinc Chloride labeling
Logged Side-Effect Incidence (14 Reports)
Gumsol (Benzocaine, Zinc Chloride) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Gumsol (Benzocaine, Zinc Chloride))
Human clinical trial evidence for Gumsol (Benzocaine, Zinc Chloride) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Gumsol (Benzocaine, Zinc Chloride) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $2.5700/unit (~$77.10/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $512.88 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 14 Anonymous DotMD Community Micro-Logs | $193.54 / mo | View logs ↓ |
Gumsol (Benzocaine, Zinc Chloride) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Gumsol (Benzocaine, Zinc Chloride) RxNorm Concept ID | 485558-B52083714 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $2.5700 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $512.88 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $193.54 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 75.00% Worth It (14 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Gumsol (Benzocaine, Zinc Chloride) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Gumsol (Benzocaine, Zinc Chloride) integrating DailyMed SPL (2025-11-15), CMS NADAC ($2.5700/unit), and 14 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Gumsol (Benzocaine, Zinc Chloride) community threads and patient logs by age, biological sex, dosage, and treatment duration.